Dr. Wise is a pulmonary, critical care physician. He is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. He is a consultant for patients with scleroderma and interstitial lung disease. He has expertise in pulmonary physiology and lung function testing. Dr. Wise’s research focus is the conduct of multi-center clinical trials in airway diseases and related translational research. Dr. Wise is the co-director of the Pulmonary T32 Multi-disciplinary Training Program in Pulmonary Disease. Dr. Wise is rated as a Distinguished provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Systemic Sclerosis (SSc), Interstitial Lung Disease, Acute Interstitial Pneumonia, and Sarcoidosis.

Dr. Danoff is an Assistant Professor in the Division of Pulmonary and Critical Care Medicine and Co-Director of the Hopkins Interstitial Lung Disease Clinic. She is a specialist in diseases causing fibrosis or scarring in the lung, particularly those associated with autoimmune diseases including myositis. Dr. Danoff is rated as a Distinguished provider by MediFind in the treatment of Lung Metastases. Her top areas of expertise are Interstitial Lung Disease, Acute Interstitial Pneumonia, Pulmonary Fibrosis, Endoscopy, and Lung Transplant.

Albert Polito is a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Polito is rated as a Distinguished provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Interstitial Lung Disease, and Acute Interstitial Pneumonia. Dr. Polito is currently accepting new patients.

Salim Rizk is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Rizk is rated as a Distinguished provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Cerebral Hypoxia, Gastrostomy, and Endoscopy. Dr. Rizk is currently accepting new patients.

Mark Gosnell is a Pulmonary Medicine specialist and a Sleep Medicine provider in Baltimore, Maryland. Dr. Gosnell is rated as a Distinguished provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Lung Metastases, Obstructive Sleep Apnea, Chronic Obstructive Pulmonary Disease (COPD), Gastrostomy, and Endoscopy. Dr. Gosnell is currently accepting new patients.

Howard Freeland is a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Freeland is rated as a Distinguished provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Lung Metastases, Pulmonary Veno-Occlusive Disease, Pulmonary Hypertension, and Chronic Obstructive Pulmonary Disease (COPD).

Puneet Garcha is a Pulmonary Medicine specialist and a Transplant Surgeon in Baltimore, Maryland. Dr. Garcha is rated as an Advanced provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Lung Metastases, and Lung Transplant. Dr. Garcha is currently accepting new patients.

Daniel Baram is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Baram is rated as an Advanced provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Atypical Pneumonia, ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), and Advanced Bronchoscopy.

Dr. Buescher is a pulmonary critical care physician. He has been deeply involved in clinical teaching of both medical students, interns, residents and fellows throughout his career. He is the director of the Medical/Surgical Critical Care Units at MedStar Union Memorial Hospital as well as MedStar Good Samaritan Hospital. He is president of a large community private practice pulmonary and critical group (Pulmonary and Critical Care Associates of Baltimore) He serves at Hopkins on the part-time clinical faculty. Research Summary Dr. Buescher is involved in multiple clinical research projects. Dr. Buescher is rated as an Advanced provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Sarcoidosis, Neurosarcoidosis, Lung Metastases, Endoscopy, and Gastrostomy.

Jonathan Rich is a primary care provider, practicing in Internal Medicine in Baltimore, Maryland. Dr. Rich is rated as an Advanced provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Heart Failure, Hypertension, Type 2 Diabetes (T2D), Heart Transplant, and Lung Transplant.

Michael Randolph is a primary care provider, practicing in Internal Medicine in Baltimore, Maryland. Dr. Randolph is rated as an Experienced provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are End-Stage Renal Disease (ESRD), Hypertensive Heart Disease, Enlarged Liver, and Pediatric Myocarditis. Dr. Randolph is currently accepting new patients.

Dr. Sarath Raju is an instructor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include obstructive lung diseases (asthma, chronic obstructive pulmonary disease), chronic lung disease in persons living with HIV, and critical care medicine. Dr. Raju earned his M.D. from Rush Medical College. He completed his residency at Johns Hopkins, where he also performed a fellowship in pulmonary and critical care medicine. He previously served as an Assistant Chief of Service for the Osler Medical Housestaff Training Program at Johns Hopkins. Dr. Raju joined the Johns Hopkins faculty in 2020, and is supported by the NIH to conduct research investigating the intersection of HIV, environmental exposures, and lung health. Dr. Raju is rated as an Advanced provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Bronchogenic Cyst, Lung Metastases, Bronchitis, and Endoscopy.

Dr. McCormack is a pulmonary, critical care physician and Associate Director of the Pulmonary & Critical Care Medicine Division. She is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. She has expertise in pulmonary physiology. She serves as the Medical Director of the Johns Hopkins University Pulmonary Function Laboratory and as the Chair of the American Thoracic Society Pulmonary Function Test Committee. She earned her M.D. from Jefferson Medical College of Thomas Jefferson University and her M.H.S. from the Bloomberg School of Public Health. She completed her residency at Thomas Jefferson University Hospital and performed a fellowship in pulmonary and critical care medicine at Johns Hopkins. She was the recipient of the Frederick L. Brancati Excellence in Mentoring Award. She plays an active role in mentoring fellows and junior faculty in the Pulmonary & Critical Care Medicine Division. Dr. Mccormack is rated as an Advanced provider by MediFind in the treatment of Lung Metastases. Her top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Asthma, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Lung Transplant.

Dr. Chen practices Pulmonary and Critical Care Medicine. His primary area of interest is sarcoidosis, and he has extensive experience in the diagnosis and treatment of sarcoidosis in all of its forms, and the management of consequences of this systemic disease. The Sarcoidosis Clinic often serves to coordinate management of patients with multi-organ involvement with sarcoidosis, and to this end Dr. Chen actively maintains clinical and research collaborations with Cardiology, Cardiovascular Nuclear Medicine, Neurology, and Ophthalmology. Additionally, Dr. Chen participates as a Physician Champion in the Johns Hopkins Health System Epic project to improve the safety and quality of care of critically ill patients through optimization of the electronic medical record. His work involves developing systems-based approaches to complex management issues, including sepsis and severe alcohol withdrawal. Dr. Chen is rated as an Advanced provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Sarcoidosis, Neurosarcoidosis, Lung Metastases, and Acute Interstitial Pneumonia.

Dr. Liu is a pulmonary physician with additional expertise in allergy and immunology. He is an expert in the diagnosis and treatment of patients with severe asthma with a focus on developing new treatments for severe disease that has failed to respond to standard therapies. Dr. Liu is rated as an Advanced provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Eosinophilic Asthma, Chronic Eosinophilic Pneumonia, Eosinophilic Pneumonia, Simple Pulmonary Eosinophilia, and Gastrostomy.

Dr. Gregory Diette is a professor of medicine at the Johns Hopkins University School of Medicine. He holds a joint appointment in the Department of Epidemiology in the Johns Hopkins Bloomberg School of Public Health. He has over 20 years of experience diagnosing and managing complex and challenging pulmonary conditions. He is expert in the diagnosis and treatment of patients with common conditions such as asthma and COPD, as well as uncommon conditions such as allergic bronchopulmonary aspergillosis (ABPA), bronchiolitis obliterans, hypersensitivity pneumonitis and others. His practice includes evaluation of patients with unexplained shortness of breath and cough as well as patients with a variety of environmental lung conditions. In addition to his outpatient practice, Dr. Diette provides inpatient care on the pulmonary, critical care and internal medicine services. Dr. Diette earned his M.D. from the Temple University School of Medicine. He completed his residency at the Hospital of the University of Pennsylvania and performed a fellowship in pulmonary and critical care medicine at Johns Hopkins. He received his M.H.S. from the Johns Hopkins Bloomberg School of Public Health. His research interests include environmental impacts on lung disease, epidemiology of airway disease and chronic obstructive pulmonary disease. Dr. Diette is rated as an Advanced provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Asthma, Allergic Bronchopulmonary Aspergillosis, Pulmonary Aspergilloma, and Aspergillosis.

Dr. Pali Dedhiya Shah is a pulmonary and critical care physician. She is an expert in the diagnosis and treatment of advanced lung disease and lung transplantation. She is the medical director of the Johns Hopkins Lung Transplant program. She is a member of the International Society for Heart and Lung transplantation and provides teaching to medical students, residents and fellows at Johns Hopkins. Dr. Shah earned her medical degree from Jefferson Medical College of Thomas Jefferson University. She completed her residency at the Hospital of the University of Pennsylvania and performed a fellowship in pulmonary and critical care medicine at Johns Hopkins. Dr. Shah joined the Johns Hopkins faculty as an assistant professor of medicine in 2011. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Lung Metastases. Her top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Lung Transplant, and Endoscopy.

Dr. Merlo is an internist who specializes in pulmonary and critical care medicine. Dr. Merlo also has clinical expertise in the care of patients with cystic fibrosis as well as clinical expertise in the care of patients with advanced lung disease who may require or have undergone lung transplantation. Dr. Merlo holds a joint appointment in epidemiology at the Johns Hopkins Bloomberg School of Public Health. Dr. Merlo attended the College of the Holy Cross and completed medical school and residency training in internal medicine at Georgetown University. He completed both clinical and research fellowships in pulmonary and critical care medicine at Johns Hopkins, and earned his M.P.H. at the Bloomberg School of Public Health. His research interests include outcomes in lung transplantation and cystic fibrosis, HIV-related pulmonary disease, and outcomes in Osler Weber Rendu. Dr. Merlo serves as the Associate Program Director of Scholarship for the Osler Medical Housestaff Training Program. He has contributed numerous scientific papers and book chapters related to cystic fibrosis and lung transplantation, and his awards include the Harry Shwachman Clinical Investigator Award from the Cystic Fibrosis Foundation. Dr. Merlo is rated as an Experienced provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Cystic Fibrosis, Secondary Immunodeficiency (SID), Aspergillosis, Lung Transplant, and Endoscopy.

Dr. Jonathan Orens is a professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include pulmonary and critical care medicine. He is an internationally recognized expert in lung transplantation. Dr. Orens received his M.D. from the University of Maryland School of Medicine. He completed his residency at the University of Maryland Medical Center and performed a fellowship in pulmonary and critical care medicine at the University of Michigan Hospitals. Dr. Orens joined the Johns Hopkins faculty in 1998. His research interests include clinical outcomes of lung transplantation, chronic allograft rejection and ischemic reperfusion injury. Dr. Orens is rated as an Experienced provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Cystic Fibrosis, Secondary Immunodeficiency (SID), Newborn Jaundice, Lung Transplant, and Endoscopy.

Stephen C. Mathai, MD, MHS is an Associate Professor of Medicine and part of the Johns Hopkins Pulmonary Hypertension Program. Dr. Mathai received his undergraduate degree from Rutgers College and medical degree from Jefferson Medical College. He pursued residency training in Internal Medicine at Thomas Jefferson University Hospital, where he also served as Chief Medical Resident. Dr. Mathai came to Johns Hopkins for fellowship training in Pulmonary and Critical Care Medicine. During his 5-year fellowship, he obtained a Masters of Health Science degree from the Johns Hopkins Bloomberg School of Public Health and successfully competed for an individual Ruth L. Kirschstein National Research Service Award. Subsequently, he received a K23 award for his research in pulmonary vascular disease in scleroderma. He currently serves as Co-Principal Investigator for the Johns Hopkins PVDOMICS program supported by the NIH and is principal investigator for a clinical trial of therapy for scleroderma associated pulmonary hypertension supported by the Department of Defense Peer Reviewed Medical Research Program. He is also the Co-Director of the Ann Dana Kusch Multidisciplinary Program for Interstitial Lung Disease and Pulmonary Hypertension. Dr. Mathai has been active in numerous committees and holds several leadership positions in academic societies. He is the current chair of the Pulmonary Vascular Disease Network for the American College of Chest Physicians and has served on the steering committee for this organization for the past 4 years. He has served on several committees for the Pulmonary Circulation Assembly of the American Thoracic Society, including the Program Committee and Nominations Committee. He has organized symposia and delivered presentations related to pulmonary hypertension at numerous international meetings. He is the author of more than 100 publications and has given invited research lectures nationally and internationally. Dr. Mathai is also an active member of patient advocacy organizations. Currently, he is a member of the Scientific Leadership Council of the Pulmonary Hypertension Association where he serves as national chairperson of the Preceptorship Program Planning Committee. He is also a member of the Rare Disease Advisory Panel for the Patient Centered Outcomes Research Institute. Dr. Mathai also serves as the faculty leader of the inpatient pulmonary service, the Carol Johns Service, where he is responsible for the education of the internal medicine housestaff and pulmonary fellows. He has also received the Frederick L. Brancati Award for mentorship from the Department of Medicine at Johns Hopkins. Dr. Mathai is rated as an Experienced provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Pulmonary Hypertension, Systemic Sclerosis (SSc), Pulmonary Veno-Occlusive Disease, Sarcoidosis, and Lung Transplant.